VA
VR Adviser Portfolio holdings
AUM
$1.33B
This Quarter Return
+100.45%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$418M
AUM Growth
+$418M
(+13%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
4.31%
Top 10 Holdings %
Top 10 Hldgs %
89.13%
Holding
25
New
9
Increased
–
Reduced
4
Closed
9
Top Buys
| 1 |
Altimmune
ALT
|
$48.2M |
| 2 |
SURF
Surface Oncology, Inc. Common Stock
SURF
|
$25.4M |
| 3 |
Keros Therapeutics
KROS
|
$25.2M |
| 4 |
VXRT
Vaxart
VXRT
|
$24.5M |
| 5 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$17.4M |
Top Sells
| 1 |
Axsome Therapeutics
AXSM
|
$47.7M |
| 2 |
Inovio Pharmaceuticals
INO
|
$21.6M |
| 3 |
10x Genomics
TXG
|
$18.7M |
| 4 |
Mersana Therapeutics
MRSN
|
$15.3M |
| 5 |
89bio
ETNB
|
$13.2M |
Sector Composition
| 1 | Healthcare | 83.36% |
